Successful engraftment after infusion of multiple low doses of CD34+ cells from a poorly matched sibling donor in a patient with severe aplastic anemia
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
The dose of CD34+ cells is known to influence the outcome of allogeneic peripheral blood stem cell (PBSC) and/or T-cell-depleted transplantation. A previous study proposed that 2×106 CD34+ cells/kg is the ideal minimum dose for allogeneic transplantation, although lower doses did not preclude successful therapy. In the case we present here, CD34+ cells were collected from a matched sibling donor on the day of allogeneic hematopoietic stem cell transplantation; however, the number of cells was not sufficient for transplantation. Consequently, PBSCs were collected three additional times and were infused along with cord blood cells from the donor that were cryopreserved at birth. The cumulative dose of total nuclear cells and CD34+ cells was 15.9×108 cells/kg and 0.95×106 cells/kg, respectively. White blood cells from this patient were engrafted on day 12. In summary, we report successful engraftment after infusion of multiple low doses of CD34+ cells in a patient with severe aplastic anemia.
Abstract
The dose of CD34+ cells is known to influence the outcome of allogeneic peripheral blood stem cell (PBSC) and/or T-cell-depleted transplantation. A previous study proposed that 2×106 CD34+ cells/kg is the ideal minimum dose for allogeneic transplantation, although lower doses did not preclude successful therapy. In the case we present here, CD34+ cells were collected from a matched sibling donor on the day of allogeneic hematopoietic stem cell transplantation; however, the number of cells was not sufficient for transplantation. Consequently, PBSCs were collected three additional times and were infused along with cord blood cells from the donor that were cryopreserved at birth. The cumulative dose of total nuclear cells and CD34+ cells was 15.9×108 cells/kg and 0.95×106 cells/kg, respectively. White blood cells from this patient were engrafted on day 12. In summary, we report successful engraftment after infusion of multiple low doses of CD34+ cells in a patient with severe aplastic anemia.
참고문헌 (15)
- Peinemann F, "Unrelated donor stem cell transplantation in acquired severe aplastic anemia: a systematic review", Haematologica, 94, pp.1732~1742 (2009)
- Copelan EA, "Hematopoietic stem-cell transplantation", N Engl J Med, 354, pp.1813~1826 (2006)
- Bacigalupo A, "Guidelines for the treatment of severe aplastic anemia. Working Party on Severe Aplastic Anemia (WPSAA) of the European Group of Bone Marrow Transplantation (EBMT)", Haematologica, 79, pp.438~444 (1994)
- Young NS, "The treatment of severe acquired aplastic anemia", Blood, 85, pp.3367~3377 (1995)
- Charbonnier A, "Immune reconstitution after blood cell transplantation", Hematol Cell Ther, 39, pp.261~264 (1997)
- Bittencourt H, "Association of CD34 cell dose with hematopoietic recovery, infections, and other outcomes after HLA-identical sibling bone marrow transplantation", Blood, 99, pp.2726~2733 (2002)
- Singhal S, "A low CD34+ cell dose results in higher mortality and poorer survival after blood or marrow stem cell transplantation from HLA-identical siblings: should 2 x 10(6) CD34+ cells", kg be considered the minimum threshold?, 2000, pp.26, 489~496
- Bacigalupo A, "How I treat acquired aplastic anemia", Blood, 129, pp.1428~1436 (2017)
- Barone A, "Diagnosis and management of acquired aplastic anemia in childhood. Guidelines from the Marrow Failure Study Group of the Pediatric Haemato-Oncology Italian Association (AIEOP)", Blood Cells Mol Dis, 55, pp.40~47 (2015)
- Killick SB, "Guidelines for the diagnosis and management of adult aplastic anaemia", Br J Haematol, 172, pp.187~207 (2016)
- Islam MS, "Implications of CD34+ cell dose on clinical and haematological outcome of allo-SCT for acquired aplastic anaemia", Bone Marrow Transplant, 45, pp.886~894 (2010)
- Pérez-Simón JA, "Minimal number of circulating CD34+ cells to ensure successful leukapheresis and engraftment in autologous peripheral blood progenitor cell transplantation", Transfusion, 38, pp.385~391 (1998)
- Perez-Simon JA, "Impact of CD34+ cell dose on the outcome of patients undergoing reduced-intensity-conditioning allogeneic peripheral blood stem cell transplantation", Blood, 102, pp.1108~1113 (2003)
- de la Rubia J, "Transplantation of CD34+ selected peripheral blood to HLA-identical sibling patients with aplastic anaemia: results from a single institution", Bone Marrow Transplant, 36, pp.325~329 (2005)
- Le Blanc K, "Transplantation of mesenchymal stem cells to enhance engraftment of hematopoietic stem cells", Leukemia, 21, pp.1733~1738 (2007)